Journal profile · Oncology
Onkologe
ISSN 0947-8965 · eISSN 2731-7234 · Springer Medizin · GERMANY · Monthly · Founded 1996
Onkologe: impact factor 0.19; subscription journal; APC about USD 3,090; median 28 days to acceptance (41 articles, last 24 months); community-reported acceptance: easy; 123 articles a year; indexed in Scopus.
Scope
Aims, scope and focus
Onkologe is published by Springer Medizin. By OpenAlex counts of its recent articles, its largest topics are Lung Cancer Treatments and Mutations, Gastric Cancer Management and Outcomes and Palliative Care and End-of-Life Issues, together about 18.1% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Zielsetzung der Zeitschrift Die Onkologie behandelt praxisnah und interdisziplinär Fragen zu Diagnose und Therapie onkologischer Erkrankungen, unter Berücksichtigung von Klinik und Praxis aller Fachrichtungen. Ein besonderer Fokus liegt dabei auf den Fachgebieten Innere Medizin, Strahlentherapie und Chirurgie. Umfassende, aufeinander abgestimmte Übersichtsarbeiten zu einem aktuellen Schwerpunktthema sind das Kernstück jeder Ausgabe. Im Mittelpunkt steht dabei evidenzbasiertes Wissen zu Diagnostik und Therapie mit hoher Relevanz für die tägliche Arbeit, einschließlich konkreter Handlungsempfehlungen. Die Schwerpunktthemen werden von einem unabhängigen Board von Herausgebenden geplant und von ausgewiesenen Expert*innen verfasst. Beiträge der Rubrik "CME Zertifizierte Fortbildung" bieten gesicherte Ergebnisse wissenschaftlicher Forschung und können zur individuellen zertifizierten Fortbildung mit dem Erwerb von CME-Punkten genutzt werden. Aims & Scope Die Onkologie deals with relevant issues concerning the diagnosis and therapy of oncological diseases. Special emphasis is placed on oncology’s interfaces with the fields of internal medicine, radiology and surgery. This interdisciplinary journal addresses the needs of researchers and doctors working in the field of oncology. The core of each issue consists of comprehensive reviews on a specific topical issue. Here the focus is on providing evidenced based information on diagnostics and therapy relevant for daily practice. After the topics are selected by an independent editorial board, established experts prepare the articles for each issue. Contributions under the rubric 'Continuing Medical Education' present the verified results of scientific research and their integration into daily practice. Review The review articles published in Die Onkologie undergo a peer review process; all other articles are reviewed by at least two experts. Declaration of Helsinki All manuscripts submitted for publication presenting results from studies on probands or patients must comply with the Declaration of Helsinki. Indexed in Science Citation Index Expanded, EMBASE and Scopus.
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Florian Lordick SocietiesPublisher website
Editorial board by country: none in mainland China; most named Germany 68, Switzerland 5, Canada 1, Netherlands 1, Austria 1 (76 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lung Cancer Treatments and MutationsMedicine7.7%
- Gastric Cancer Management and OutcomesMedicine5.4%
- Palliative Care and End-of-Life IssuesMedicine5%
- Ovarian cancer diagnosis and treatmentMedicine4.6%
- Endometrial and Cervical Cancer TreatmentsMedicine4.5%
- Cancer Diagnosis and TreatmentMedicine4.5%
- Colorectal Cancer Treatments and StudiesMedicine4.3%
- Cancer survivorship and careMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEEmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.19LetPub ·
- Impact factor (publisher) 2025
- 0.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.3Publisher website ·
- CiteScore 2026-06
- 0.4LetPub ·
- SJR 2026-06
- 0.12LetPub ·
- SNIP 2026-06
- 0.13LetPub ·
- h-index
- 12LetPub ·
- h-index
- 20OpenAlex ·
- i10-index
- 103OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 4.62%LetPub ·
Volume
- Articles per year
- 123LetPub ·
- Downloads per year (publisher) 2025
- 225,900Publisher website ·
Articles by year OpenAlex count · 4,166 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2022 | 79 | 17 | 63 |
| 2021 | 179 | 34 | 264 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
28 daysMedian, submission to acceptance · P25–P75 9 days – 58 days
- Acceptance to online
- median 34 days (87 articles)
- Submission to online
- median 63 days
- Sample
- 41 articles with submission and acceptance dates (419 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,090 / EUR 2,590 / GBP 2,190 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteData availability, Publication ethics, Open access
- Data availability Data availability statements
Research data policy: sharing encouraged; Data Availability Statement required for original research articles. Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics
Journal is a COPE member and follows COPE guidelines for handling misconduct. Model summary
Diese Zeitschrift sieht sich in der Pflicht, die Integrität wissenschaftlicher Publikationen sicherzustellen. Als Mitglied des Committee on Publication Ethics (COPE) orientiert sie sich an den COPE-Leitlinien für den Umgang mit möglichen Verstößen gegen die Regeln der guten wissenschaftlichen Praxis.
Source ↗Publisher website ·- Open access Open access publishing
Open access publishing page covers fees, funding and licences. Model summary
To find out more about publishing your work Open Access in Die Onkologie, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Medizin
- Country or region
- GERMANY
- Language
- German
- Frequency
- Monthly
- Founded
- 1996
- ISSN
- 0947-8965
- Print ISSN
- 2731-7226
- Electronic ISSN
- 2731-7234
- Latest issue on the website
- Volume 32, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Onkologe
What is the impact factor of Onkologe?
The latest impact factor listed by LetPub is 0.19; CiteScore 0.4, h-index 20.
How long does peer review take at Onkologe?
Based on the dates recorded on 41 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 28 days (interquartile range 9–58 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Onkologe based?
Of the 76 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Germany (68), Switzerland (5) and Canada (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Onkologe?
According to LetPub and DOAJ records, Onkologe is indexed in Scopus. The journal's website also lists SCIE and Embase; that list has not been checked against each database.
Is Onkologe open access, and what is the APC?
Onkologe is a subscription journal. APC about USD 3,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .